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Abstract  
Objective: To compare meta-analyses of diagnostic test accuracy using the Moses-Littenberg 
summary ROC (SROC) approach with those of the hierarchical SROC (HSROC) model.  
Study design and setting: Twenty-six datasets from existing test accuracy systematic reviews were 
reanalysed with the Moses-Littenberg model, using equal weighting (‘E-ML’) and weighting by the 
inverse variance of the logDOR (‘W-ML’), and with the HSROC model. The diagnostic odds ratios 
(DOR) were estimated and covariates added to both models to estimate relative DORs (RDORs) 
between subgroups. Models were compared by calculating the ratio of DORs, the ratio of RDORs and 
P-values for detecting asymmetry and effects of covariates on DOR.  
Results: Compared to the HSROC model, the Moses-Littenberg model DOR estimates were a median 
of 22% (‘E-ML’) and 47% (‘W-ML’) lower at Q*, and 7% and 42% lower at the central point in the data.  
Instances of the ML-models giving estimates higher than the HSROC model also occurred.  
Investigations of heterogeneity also differed; the Moses-Littenberg models on average estimating 
smaller differences in RDOR.  
Conclusions: Moses-Littenberg meta-analyses can generate lower estimates of test accuracy, and 
smaller differences in accuracy, compared to mathematically superior hierarchical models.  This has 
implications for the usefulness of meta-analyses employing this approach. We recommend meta-
analysis of DTA studies to be conducted using available hierarchical model based approaches.  
 
Keywords: diagnostic test accuracy, meta-analysis, systematic review, hierarchical models, diagnostic 
odds ratio, summary ROC curves.  
Running title: Comparison of meta-analytic approaches for diagnostic test accuracy data 
 
Word count (excl Abstract, Tables and Figures): 3886 
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What is new 
• The Moses-Littenberg model for meta-analysing diagnostic test accuracy data on average 
generates lower estimates of test accuracy in comparison to the  hierarchical summary ROC 
method for meta-analysis 
• Substantial differences in results of investigations of heterogeneity between models are 
produced, both for estimates of the size of the effect and its statistical significance.   
• Our findings support and extend those of a previous empirical comparison of methods, further 
raising concerns around the use of the results of Moses-Littenberg meta-analyses in clinical 
practice. 
• Evidence for current recommendations for the preferential use of hierarchical models for 
diagnostic test meta-analyses is provided and should further encourage their uptake. 
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1. Introduction  
There is a considerable body of systematic reviews and meta-analyses of diagnostic test accuracy 
(DTA) in the public domain [1, 2]. Meta-analysis allows more precise estimation of test accuracy, can 
provide a stronger comparison of the accuracy of different tests compared to a single study, and 
allows the inevitable variability between studies to be quantified and formally investigated, as and 
when there is sufficient cause to suspect clinical or methodological variability [3, 4]. The statistical 
pooling of test accuracy studies presents an added level of complexity over and above that presented 
by trials of therapeutic interventions. Accuracy is usually quantified by two related statistics (sensitivity 
and specificity) rather than one, and meta-analysis must allow for the trade-off between the two. 
Approaches to DTA meta-analysis include separate pooling of sensitivity and specificity estimates, the 
linear regression approach to estimating summary ROC (SROC) curves developed by Moses and 
Littenberg (referred to here as Moses-Littenberg) [5, 6], and methods based on hierarchical models 
[7-11].  
 
The theoretical limitations and advantages of the different meta-analytical approaches are well 
documented [12-14].  Whilst the Moses-Littenberg approach accounts for the bivariate nature of the 
data and the inverse correlation between sensitivity and specificity, it does not appropriately model 
within and between study variability to account for the uncertainty in the estimates, such that 
confidence intervals and hypotheses tests from the model are possibly invalid and summary operating 
points are hard to estimate.  The hierarchical models preserve the bivariate nature of test accuracy 
data in terms of both model parameterisation and interpretation, accounting for the correlation 
between sensitivity and specificity; they appropriately weight studies to account for within study 
variability; and use a random effects approach to account for between-study variability. They also 
allow estimation of the diagnostic odds ratio (DOR) and an average operating point in terms of or 
sensitivity specificity pair, with associated confidence and prediction regions.   
 
The hierarchical models have been recommended for DTA meta-analyses by the Cochrane 
Collaboration since 2007 [3].   However, the Moses-Littenberg model was used in 43% of 760  meta-
analyses of diagnostic or predictive accuracy published between 1987 and 2009, and made up 86% 
of all meta-analyses that used ROC approaches to synthesis [15]. A survey of 100 DTA meta-
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analyses published between September 2011 and January 2012 found that over half continued to 
pool studies using either simple linear regression-based SROC analysis or a univariate approach, and 
not the preferred hierarchical models [16]. Three-quarters of corresponding authors for 24 of the 
reviews using these ‘traditional’ approaches believed the approach to be “currently recommended” 
and 71% “believed that the method yielded precise estimates” [16].   Meta-analyses undertaken prior 
to this period are even more likely to have used the mathematically inferior models [1, 2].    
 
Available empirical studies examining the impact of choice of meta-analytic model on overall results 
have reached conflicting conclusions, noting that hierarchical models produce different results to 
simpler models [14] or suggesting that conclusions may not differ [17, 18].  None of these studies 
considered possible effects on investigations of heterogeneity, such as looking at differences between 
tests or subgroups.  
 
Given the widespread use of the Moses-Littenberg meta-analysis model there is a need to identify 
and quantify any potential differences in estimates of test accuracy and in investigations of sources of 
heterogeneity. The complexity of the hierarchical models and their omission from commonly used 
meta-analytical software programs [19]  further compounds the need to determine the degree to 
which results might be affected by the choice of approach.   Our objective was to empirically compare 
the Moses-Littenberg and hierarchical SROC (HSROC) approaches for the overall synthesis of DTA 
data and for the investigation of sources of heterogeneity using a large sample of systematic reviews.  
 
2. Methods 
2.1. Identification, extraction and analysis of systematic review data  
Existing test accuracy systematic reviews were identified from the Database of Abstracts of Reviews 
of Effects (DARE), the HTA database of the Cochrane Library and the MEDION database of 
systematic reviews. The cohort we analysed has been partially reported on previously [1], and 
includes reviews published between 2000 and 2005 that presented sufficient information to allow the 
construction of a 2x2 contingency table comparing a test to a reference test for at least five primary 
studies. Systematic reviews had to include at least five studies and report at least one study-level 
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covariate. One reviewer assessed whether reviews met these criteria.   All subgroups in the dataset 
contained at least 3 studies.   
 
Data on the experimental test and target disorder, the 2x2 contingency table data and data on any 
potential spectrum-related sources of heterogeneity per study were extracted independently by two 
reviewers. Disagreements were resolved by consensus or referral to a third reviewer.  
 
2.2 Meta-analytical methods 
Three alternative meta-analytical methods were considered, two formulations of the Moses-Littenberg 
model with different study weighting, and the HSROC model. 
The Moses-Littenberg model was fitted as originally described [5, 6].  The approach involves 
computing the logit-transforms of sensitivity and the complement of specificity and undertaking a 
linear regression of the difference between them (D, or the log of the DOR) on the sum (S, a measure 
of the proportion that are test positive, which is a proxy for test threshold) to estimate an intercept 
parameter α and a slope parameter β. A summary ROC curve is derived from the fitted regression 
line.  The test of the significance of the slope β is used to determine whether there is evidence that 
the DOR varies with the threshold parameter S, which implies that the summary ROC curve has an 
asymmetric shape.  Differences between subgroups in the log DOR can be investigated by adding 
indicator variables as covariates. The parameter estimates for these are the log relative DOR (RDOR) 
comparing the DOR between the subgroups. Inclusion of interactions between each covariate and the 
S parameter allows for different shaped curves in each subgroup.  We fitted models with and without 
the interaction term.  The regression intercept term estimates the log of the DOR at the Q* point, 
where sensitivity is equal to specificity. We used the DOR value at this point in accuracy comparisons, 
but as it may lie outside the results of the observed studies we also made comparisons of the DOR 
estimated at the mean value of S which will be central to the observed study results. We fitted the 
Moses-Littenberg model giving equal weight to all studies (denoted ‘E-ML’), and weighting each study 
(denoted ‘W-ML’) by the inverse variance of the log DOR, in accordance with standard practice [12]. A 
standard zero cell correction (the addition of 0.5 to every cell of a 2x2 table that contains at least one 
zero) was used to avoid divide by zero errors.   
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Two versions of the hierarchical model are commonly used for meta-analysis, the HSROC and the 
bivariate models, which have been shown to be mathematically equivalent for single test meta-
analyses but to estimate different parameters in investigations of heterogeneity [14].  We chose the 
HSROC model for comparison with the Moses-Littenberg models as both estimate RDOR in 
heterogeneity investigations.   We fitted the HSROC model proposed by Rutter and Gatsonis [7, 8] 
which is based on a latent scale logistic regression model [20, 21]. The HSROC model assumes that 
there is an underlying ROC curve in each study with parameters α and β which characterize the 
accuracy and asymmetry of the curve, in a similar way to the α and β parameters in the linear 
regression method of Moses and Littenberg. The parameter α estimates log DOR at the Q* point and 
the significance of the shape term β can be used to assess whether a symmetric or asymmetric curve 
best fits to observed data.  The model has a third parameter θ related to the proportion test positive – 
its value is equivalent to the values of S/2 in the Moses-Littenberg model. An average value for θ is 
estimated by the model, which allows identification of an average operating point on the summary 
ROC curve central to the observed data. The model is fitted at two levels.  At the first level the 
proportions test positive in the reference standard positive and negative groups are modelled 
assuming they follow a binomial distribution, whereas at the second level variation between studies is 
modelled assuming normal distributions for log DOR (α) and the positivity threshold parameter (θ). To 
investigate heterogeneity using the HSROC model, we fitted parallel SROC curves by adding the 
covariate as a term to both the accuracy and threshold parts of the model (such that the shape of the 
SROC curves is determined using the whole set of studies).  We also fitted models that included a 
covariate as a third term in the shape part of the model, to allow for variation in differences in log DOR 
with threshold (allowing the SROC curves to have different shapes; non-parallel).   
2.3. Comparison of meta-analytic models 
We compared the performance of each Moses-Littenberg regression model with the results of the 
HSROC model first for a simple meta-analysis by: 
i) comparing DOR estimates by computing the ratio of DOR from the Moses-Littenberg models 
compared to the HSROC model at the central point in the data (which is the equivalent of the 
average operating point) and at the Q* value (the point where sensitivity=specificity) (sample 
SROC curves from each model shown in Box 1);  
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ii) comparing the detection of SROC curve asymmetry between the Moses-Littenberg and 
HSROC models by comparing P-values from Wald tests for the β term in both models; 
and then in investigations of heterogeneity contrasting two subgroups 
iii) comparing estimates of the RDOR between the Moses-Littenberg models and the HSROC 
model  again at the central point in the data and at Q*; and 
iv) comparing the significance of the difference in DOR between the models estimated by 
comparing P-values from Wald tests for the log RDOR terms in both models. 
For the Moses-Littenberg model we identified the central point in the data as being at the mean value 
of S, whilst for the HSROC model we identified it as being at the average operating point. For the 
comparison of subgroups, the RDOR can be less than or greater than one; summary statistics were 
standardised to code the subgroups such that the HSROC model always estimated an RDOR greater 
than one.     
Box 1 Sample SROC curves estimating using Moses-Littenberg and HSROC models (estimates 
using data from Scheidler et al [22] 
 
E-ML – equal weight Moses-Littenberg  model; W-ML – Moses-Littenberg model weighted by inverse variance of 
D; HSROC – hierarchical SROC model; DOR – diagnostic odds ratio; Q* - DOR plotted at point on SROC curve 
where sensitivity=specificity; average operating point  – DOR point on the SROC curve near to the centre of the 
data using mean threshold.   
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We additionally investigated how differences in DOR between the models vary according to 
predefined aspects of a) magnitude of accuracy, b) prevalence of zero cells, c) variation in threshold 
(based on values for ‘S’ from the Moses-Littenberg model).  
 
The Moses-Littenberg analyses were performed in STATA and the HSROC model was carried out 
using the PROC NLMIXED command in SAS.  
3. Results 
3.1. Search results 
The search identified 97 systematic reviews of test accuracy that presented sufficient data to 
complete 2x2 contingency tables per study (Figure 1). Information on at least one covariate per study 
was presented in 29 reviews, however the HSROC model would not converge for three of the 
datasets (occasional non-convergence of the HSROC model, particularly when there are few studies 
or when all studies sit on one of the boundaries of SROC space is a recognised phenomenon [23]). 
The comparisons between models are therefore based on 26 datasets with a total of 55 spectrum-
related covariate investigations (Supplementary Table 1). The HSROC model could not be completed 
for 9 covariate investigations (for one parallel curve SROC comparison, for four non-parallel curve 
SROC comparisons and for four covariates using both parallel and non-parallel SROC curves), either 
due to insufficient numbers of studies in at least one of the subsets (for 5 of the 9 covariates) or the 
studies exhibited exceptionally high specificities with varying sensitivities. The median number of 
studies per review was 16 (IQR 12, 26); median sample sizes of studies within each review ranged 
from 20 to 7575.  
 
3.2. Comparison of diagnostic odds ratios 
Estimates of the DOR from the Moses-Littenberg methods were on average lower than those of the 
HSROC model.  Evaluated at the Q* point, the ‘E-ML’ model estimates of the DOR were a median of 
22% lower (IQR 49% lower to 2% higher) than those from the HSROC model, whilst estimates from 
the ‘W-ML’ model were a median of 47% lower (IQR 76% lower to 28% lower). Differences between 
models were smaller at the central threshold, but still showed lower estimates for the Moses-
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Littenberg models on average: 7% lower (IQR 32% lower to 4% higher) for ‘E-ML’ and 42% lower 
(IQR 64% lower to 22% lower) (Figure 2a).  
 
We categorized the meta-analyses according to their DOR estimate from the HSROC model, the 
percentage of studies with zero cells in 2x2 tables, and the range of the threshold parameter S (Table 
1).  We noted greater discrepancy between the methods when DORs were high and with increasing 
percentages of zeros in 2x2 tables.  There was no clear relationship with the range of the threshold 
parameter.  
 
A wide range in results was observed for all model comparisons with both higher and lower estimates 
for Moses-Littenberg models compared to HSROC models (Figure 2b). The five reviews responsible 
for most of the extreme differences of DOR all had studies with very high or close to perfect sensitivity 
[24, 25] and/or specificity [26-28] (Supplementary Figure 1). The lack of data points near to Q* for 
these reviews illustrates the unreliability of DORs estimated at this point. The three datasets that 
produced extreme values in all analyses were removed in a sensitivity analysis [24, 25, 28]; 
differences in DOR estimates between Moses-Littenberg and HSROC models remained for both the 
‘E-ML’ and ‘W-ML’ model comparisons (the overall range in RORs being 0.48 to 1.20 and 0.24 to 
1.13, respectively) (analysis not shown).  
 
3.3. Comparison of SROC curve shape 
Figure 3 shows broad but imperfect agreement between the HSROC and Moses-Littenberg models in 
terms of tests of the asymmetry of the SROC curve. Taking P<0.20 as providing moderate to strong 
evidence of curve asymmetry, SROC curve asymmetry was identified for 14 of the 26 datasets using 
the HSROC model and 12 datasets for each of the Moses-Littenberg models, with 4 and 3 reviews 
showing disagreement for the ‘E-ML’ and ‘W-ML’ models respectively.  
 
3.4. Comparison of estimates of RDOR in heterogeneity investigations  
Estimates of RDOR from heterogeneity investigations were on average considerably lower when 
estimated by the Moses-Littenberg models compared to the HSROC model (Figure 4). When 
estimated assuming parallel SROC curves, RDOR values (median [IQR]) were 13% lower [42% lower 
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to 2% higher] for the ‘E-ML’ model and 20% lower [46% lower to 5% higher] for the ‘W-ML’ model.  
Including interaction terms to allow for non-parallel SROC curves substantially increased both the 
average difference and the range of differences when evaluated both at the Q* point and the central 
point. 
 
3.4. Comparison of the statistical significance of sources of heterogeneity 
There was poor agreement in the statistical significance of the covariate investigations between 
Moses-Littenberg and HSROC models with the P-value comparison points scattered widely around 
the plots (Figure 5). Disagreements appeared worse for the models with non-parallel SROC curves.   
4. Discussion 
We found that the simpler Moses-Littenberg models produced lower estimates of DOR accuracy in 
comparison with the more complex HSROC model, with median differences of 22% and 47% for 
unweighted and weighted models at Q*, but with wide inter-quartile and overall ranges for the 
differences. The greatest differences were observed when the Moses-Littenberg model was weighted 
by the inverse variance of lnDOR, where the overall pooled DOR was over 100, and where there were 
a high proportion of zero cells; situations where the mathematical limitations of Moses-Littenberg 
method creates misleading estimates.  
The weighted Moses-Littenberg model uses the approximate asymptotic standard error of the log 
DOR in allocating study weights.  We have previously shown (in the context of funnel plots and tests 
for publication bias [29]) that the estimate of the standard error depends on the ln DOR for values of 
DOR which are greater than one, leading funnel plot based tests such as the Begg and Egger tests to 
overestimate the frequency of sample size related effects.  The same relationship will affect the 
estimates of standard errors for larger DOR, most often leading to overestimation of standard errors 
at higher DOR, which in an inverse variance weighted meta-analysis will lead to underestimation of 
overall accuracy.  
Zero-cell corrections are used in the Moses-Littenberg model when sensitivities or specificities of 
100% are observed, also when the DOR is typically high. Adding 0.5 to each cell of every 2x2 
contingency table that contains zero false positives or false negatives always creates a downward 
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effect on the estimate of the DOR.   The magnitude of effect will be greater in studies with smaller 
sample sizes in the disease positive and disease negative groups. 
There was some disagreement in detection of SROC curve asymmetry between models, but the 
asymmetry detected was rarely statistically significant with either model. Many of our analyses 
contained few studies thus few of the meta-analyses will have had enough power to detect 
asymmetry.  
Of importance, we observed substantial differences for investigations of heterogeneity, both in terms 
of the estimates of the size of the effect (RDOR) and their statistical significance. In line with their 
performance for simple test meta-analyses, Moses-Littenberg methods on average generated lower 
between group differences in accuracy compared to the HSROC model.  The failure of the ML models 
to account for both within and between study variability compromises the models’ ability to estimate 
standard errors used to assess statistical significance, leading to a  notable lack of agreement in the 
statistical significance of relative diagnostic odds ratios. Inferences drawn from covariate 
investigations using the Moses-Littenberg models can therefore potentially be highly spurious.   These 
findings have implications for meta-analyses that compare tests as well as those which investigate the 
performance of a single test in subgroups of studies. 
 
Our results support and extend those of previous empirical comparisons (one using a very large 
dataset [15]) showing that SROC curves produced by the simpler Moses-Littenberg model can appear 
similar to those produced by more rigorous methods but can in some cases diverge [14, 15]; neither 
of these comparisons compared average operating points on the SROC curves however, and neither 
compared the results of heterogeneity investigations. Whilst our dataset has shown that although in 
some circumstances there may be little difference on average between methods, the variability 
observed around the average indicates the potential for large differences in test accuracy, both in the 
overall result of the meta-analysis and, perhaps more crucially, with the addition of covariates to the 
models.  
 
Our comparison of models is subject to a number of limitations. Studies in our cohort were published 
between 2000 and 2005 with screening for inclusion conducted by only one reviewer. However, given 
that our purpose was to illustrate the potential effect across a number of datasets rather than to reach 
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a conclusion around the accuracy of a given test, the potential for reviewer bias is limited. 
Furthermore the currency of the review cohort has no impact on the statistical models used or 
external validity of our results as there is no reason to consider that the relationships between the 
methods would differ in more recent studies.  In terms of the statistical analyses, heterogeneity was 
common and the number of studies per meta-analysis were typical but low, with a median of 16 
(range 7 to 46). These factors will have contributed to some of the extreme results observed but many 
review authors will nevertheless make the decision to meta-analyse studies in these circumstances.   
 
Furthermore, we focused on comparing DORs rather than sensitivity and specificity estimates as the 
DOR is the natural parameter of both the Moses-Littenberg and HSROC models.  This facilitated the 
comparison between models to be illustrated with a single parameter, however the DOR is not as 
intuitive as other measures of test accuracy. When we looked at summary estimates of sensitivity and 
specificity at the average operating point and at Q*, the ML model produced at least one estimate in 
the order of 5% to 9% lower than the HSROC model in 12 of the 26 reviews, and 10% to 23% lower 
than the HSROC model for 8 of the 26 reviews. Only one review produced an estimate that was 
higher than that observed from the HSROC model (for the E-ML estimate of sensitivity).  Although the 
differential effects on sensitivity and specificity vary from case to case, the directional ‘bias’ that we 
observed for the ML model in the DOR comparisons was supported by the comparisons of 
sensitivities and specificities, with differences large enough to mislead.  
 
The strength of this study was the number of datasets available for reanalysis. Further investigation, 
for example using simulated data, might be able to identify circumstances under which the Moses-
Littenberg methods more closely approximate those of the HSROC method.  Whilst there are more 
limited software options for fitting hierarchical models than the Moses-Littenberg models, requiring 
programs that fit mixed linear (or non-linear for the HSROC) logistic models, support for fitting these 
models in SAS, STATA, R and WinBUGS, is now available such that they should be the preferred 
approach [30, 31]. Whilst convergence problems with the HSROC and bivariate model are 
encountered when there are few studies, fitting HSROC models with fewer parameters (e.g. setting 
variance parameter estimates to zero, or assuming symmetrical SROC curves) has been found to be 
a preferable approach .   
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We have provided empirical evidence that supports current recommendations advocating the use of 
hierarchical approaches to the statistical synthesis of test accuracy data [30, 31]. Ongoing efforts to 
extend the scope of the models [32-34] and to make them more accessible [35-37] should help to 
increase their uptake in future systematic reviews. 
 
These findings raise concerns about the clinical use of existing reviews that have employed the 
Moses-Littenberg approach. We have demonstrated that not only might the pooled results be 
misleading, but conclusions drawn from models where covariates have been added may also be 
unreliable. This finding applies not only to investigations of heterogeneity but also to comparisons of 
the accuracy of two or more tests where test covariates are added to the models in the same way as 
for sources of heterogeneity.  The problem may not be considered as serious where investigations 
are considered exploratory, but is of real concern where comparisons between tests are made with 
the aim of informing the selection of tests for use in clinical practice.  Our results also potentially call 
into question the conclusions from seminal meta-epidemiology papers that have employed the 
Moses-Littenberg model to provide the basis for our understanding of the biases in operation in test 
accuracy studies [2, 38, 39]. 
  
There are a huge number of systematic reviews of diagnostic tests now in the public domain, many of 
which have employed less than optimal approaches to the synthesis of test accuracy data. We have 
demonstrated the potential for drawing misleading inferences from meta-analyses adopting the 
Moses-Littenberg model and recommend that caution is used when considering their use. Our 
findings support and encourage the future uptake of hierarchical models for diagnostic test meta-
analyses.  
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Table 1 Stratified comparison of diagnostic odds ratio (DOR) estimates 
 Comparison of DORs at mean threshold* 
Number of reviews E-ML vs HSROC W-ML vs HSROC 
 median ROR [IQR] median ROR [IQR] 
 
  
Overall (n=26) 0.94 [0.68, 1.04] 0.59 [0.46, 0.78] 
 
  
by size of DOR†   
DOR < 35, n=9 0.99 [0.88, 1.16] 0.78 [0.60, 0.95] 
DOR 35-100, n= 10 1.00 [0.83, 1.05] 0.53 [0.42, 0.69] 
DOR > 100, n= 7 0.62 [0.30, 0.75] 0.42 [0.16, 0.59] 
 
 
 
by % zero cells‡  
 
<5%, n=10 1.01 [0.88, 1.05] 0.79 [0.53, 0.88] 
5 to 10%, n=8 1.02 [0.94, 1.11] 0.63 [0.50, 0.74] 
>10%, n=8 0.62 [0.30, 0.72] 0.42 [0.16, 0.63] 
 
 
 
by range in 'S'∫   
range 3 to <6, n=7 0.82 [0.48, 1.03] 0.75 [0.37, 0.79] 
range 6 to <8, n=14 0.90 [0.68, 1.00] 0.53 [0.49, 0.75] 
range ≥8, n=5 1.05 [0.99, 1.16] 0.57 [0.42, 0.73] 
 
DOR – diagnostic odds ratio; E-ML – equal weight Moses-Littenberg model; W-LM – weighted Moses-Littenberg 
model; ROR - ratio of DORs between models;  median ROR – ROR at the median; IQR – inter quartile range in 
ROR, from 25th percentile to 75th percentile 
 
* Each Moses-Littenberg model is compared to the HSROC model (denominator) 
†
 The stratification by DOR is based on the HSROC overall pooled estimate at mean threshold 
‡
 number of zero false positive and false negative cells as a percentage of the total number of cells per analysis 
∫ based on values for ‘S’ from Moses-Littenberg model, where S = logit(sensitivity) + logit(1 - specificity) 
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Figure 1 Flowchart of the review selection process 
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Figure 2 Comparison of diagnostic odds ratios: ML models versus HSROC model 
 
a. Box and whisker plot of ratio of DORs between models (HSROC model estimate as 
reference) 
 
 
 E-ML W-ML  E-ML W-ML  
 Q*  mean threshold  
─ max 2.77 1.28  1.2 1.13  
p75 1.02 0.72  1.04 0.78  
─  p50 0.78 0.53  0.935 0.585  
p25 0.51 0.24  0.68 0.46  
─ min 0.07 0.10  0.05 0.03  
 
b. Scatter plot of ratio of DORs between models (HSROC model estimate as reference) 
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E-ML – equal weight Moses-Littenberg  model; W-ML – Moses-Littenberg model weighted by inverse variance of 
D; HSROC – hierarchical SROC model; DOR – diagnostic odds ratio; Q* - point on SROC curve where 
sensitivity=specificity; mean threshold – point on the SROC curve near to the centre of the data;  max – 
maximum ratio of DORs ; p75 – ratio of DORs at the 75th percentile; p50 – ratio of DORs at the 50th percentile 
(median); p25 – ratio of DORs at the 25th percentile; min – minimum ratio of DORs; [ ] denotes reference number 
for five reviews responsible for most of the extreme differences of DOR 
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Figure 3 Comparison of test of statistical significance of SROC curve asymmetry 
a. E-ML versus HSROC b. W-ML versus HSROC 
  
 
E-ML – equal weight Moses-Littenberg model; W-ML – Moses-Littenberg model weighted by inverse variance of 
D; HSROC – hierarchical SROC model 
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Figure 4  Ratio of relative DORs (RDORs) between models (HSROC model estimate as 
reference) 
 
 
 
 
 E-ML W-ML E-ML W-ML E-ML W-ML  
 Parallel curves at Q* Non-parallel curves at Q* Non- parallel curves at 
reference group threshold 
 
─ max 1.93 1.90 76.78 35.63 4.69 11.82  
p75 1.02 1.05 1.63 1.45 1.26 1.10  
─  p50 0.87 0.80 0.61 0.76 0.70 0.64  
p25 0.58 0.54 0.25 0.26 0.34 0.39  
─ min 0.02 0.05 0.0004 0.0002 0.00009 0.0001  
 
DOR – diagnostic odds ratio; RDOR – relative diagnostic odds ratio; E-ML – equal weight Moses-Littenberg  
model; W-ML – Moses-Littenberg model weighted by inverse variance of D; HSROC – hierarchical SROC 
modelparallel curves – R DORs between study subgroups estimated assuming SROC curves have same shape 
(parallel); non-parallel curves - R DORs between study subgroups estimated allowing  SROC curves to have 
different shapes (non-parallel); Q* - point on SROC curve where sensitivity=specificity; reference group threshold 
– RDOR estimated at the point on the SROC curve near to the centre of the data in the reference group;  max – 
maximum ratio of DORs ; p75 – ratio of DORs at the 75th percentile; p50 – ratio of DORs at the 50th percentile 
(median); p25 – ratio of DORs at the 25th percentile; min – minimum ratio of DORs;  
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Figure 5 Comparison of tests of statistical significance for difference in accuracy 
 
 a. E-ML versus HSROC b. W-ML versus HSROC 
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E-ML – equal weight Moses-Littenberg  model; W-ML –Moses-Littenberg model weighted by inverse variance of 
D; HSROC – hierarchical SROC model 
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